Alcohol Use Disorder (AUD) is a major cause of morbidity and mortality in the U.S. Individuals of color are particularly impacted by more severe health and social consequences related to alcohol use and experience greater barriers to treatment. Supported by a $3.5M grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), faculty in the Yale Program in Addiction Medicine and the Yale Department of Psychiatry have partnered to implement a three-arm trial that will investigate the optimal approach to enhance post-discharge AUD treatment engagement and reduction of alcohol use.
More from Yale School of Medicine
Published: Monday, November 1, 2021
